ClinicalTrials.Veeva

Menu

Relationship Between Hyperventilation Syndrome and SARS-CoV-2 Infection (Hypercovid)

C

Central Hospital, Nancy, France

Status

Completed

Conditions

COVID-19
Hyperventilation Syndrome

Treatments

Other: Nijmegen questionnaire score

Study type

Observational

Funder types

Other

Identifiers

NCT05224830
2021PI224-203

Details and patient eligibility

About

Following an acute COVID-19 infection, many patients suffer from long lasting physical symptoms that may greatly impair quality of life. Persisting dyspnea and other functional respiratory complaints could evoke Hyperventilation Syndrome (HVS) as a putative contributor of the long-COVID presentation in COVID-19 survivors. We aimed to assess the possible relationship between a HVS and previous acute SARS-CoV-2 infection.

Enrollment

2,846 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Read and speak French
  • Perform a pulmonary function test

Exclusion criteria

  • incomplete questionnaire or inability to obtain an interpretable lung function assessment

Trial design

2,846 participants in 2 patient groups

Presence of Hyperventilation Syndrome (HVS+)
Description:
Study population was divided into two groups according to the diagnosis of Hyperventilation Syndrome HVS +- : Nijmegen questionnaire score \> 23/64
Treatment:
Other: Nijmegen questionnaire score
No presence of Hyperventilation Syndrome (HVS-).
Description:
Study population was divided into two groups according to the diagnosis of Hyperventilation Syndrome HVS - : Nijmegen questionnaire score \< 24/64
Treatment:
Other: Nijmegen questionnaire score

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems